Search the Newsreel

NervGen Pharma (NASDAQ:NGEN) Stock Rating Lowered by Wall Street Zen

Generac Holdings Inc (GNRC) News, Articles, Events & Latest Updates

This article provides recent news and updates concerning Generac Holdings Inc. (GNRC), including analyst price targets suggesting a significant upside and discussions on the company's performance relative to its sector. It highlights Generac's strong data center backlog and the impact of recent earnings reports …

Lasa Supergenerics reports standalone net loss of Rs 3.58 crore in the June 2026 quarter

Genesys International Corporation consolidated net profit declines 25.14% in the June 2026 quarter

Merus Global Investments (GFUZ) reports 0% ownership in General Fusion Group Ltd.

Merus Global Investments, LLC has filed an amended Schedule 13G, indicating that it no longer holds a reportable position in General Fusion Group Ltd. Class A ordinary shares. The firm now reports 0% beneficial ownership, with no voting or dispositive power over any shares. …

General Mills (GIS) Stock Looks Near Fair Value After Its Reset

Vistagen Therapeutics (VTGN) flags going concern risk amid Q1 loss and Nasdaq pressure

Vistagen Therapeutics reported a net loss of $13.0 million for Q1 2027, an improvement from the prior year, with revenue increasing to $1.5 million. Despite this, the company flagged substantial doubt about its ability to continue as a going concern due to high operating …

William Blair Maintains VistaGen Therapeutics(VTGN.US) With Hold Rating

William Blair has reiterated its Hold rating for VistaGen Therapeutics (VTGN.US). The report from the investment firm indicates their continued neutral stance on the company's stock.

Q1 2026 Lithium Argentina AG Earnings Call Transcript

Wie sich die vertraglich abgesicherte Nachfrage im Luftfahrt- und Energiesektor auf die Anleger von General Electric (GE) auswirken wird

General Motors (GM) Restarts Ohio Battery Production After Seven Month Shutdown

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Ultium Cells, the General Motors (NYSE:GM) and LG Energy Solution joint venture, restarted battery production at its Warren, Ohio plant after a seven month shutdown …

Neogen Corp (NEOG) grants 196,276 options and 38,627 PSUs to Chief Legal Officer

Neogen Corp (NEOG) has granted its Chief Legal Officer, Stacey Jennifer Evans, equity compensation awards. These awards include options to acquire 196,276 shares of common stock at an exercise price of $11.65 per share, vesting over three years, and 38,627 performance stock units (PSUs) …

Neogen Corp (NEOG) grants CFO 261,702 options and 51,502 PSUs in equity awards

Neogen Corp (NEOG) has granted its CFO, Richard Bryan Riggsbee, equity awards consisting of 261,702 stock options and 51,502 Performance Share Units (PSUs). The options have an exercise price of $11.65 per share and vest in equal annual installments over three years, while the …

Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?

On August 11, Gilead Sciences, Inc. (NASDAQ:GILD) exercised its option to exclusively license a preclinical bispecific program targeting solid tumors using MacroGenics, Inc. (NASDAQ:MGNX)'s proprietary TRIDENT platform. The decision triggered a $10 million milestone payment to MacroGenics, injecting momentum into the companies' 2022 collaboration. …

NEOGEN CORP (NEOG) CEO awarded 719,679 options and 141,631 PSUs in equity grant

NEOGEN CORP CEO Mikheal Nassif was granted 719,679 stock options with an exercise price of $11.65 and 141,631 performance stock units (PSUs) on August 14, 2026. The stock options vest in equal annual installments over three years, while the PSUs vest entirely on the …

These Analysts Revise Their Forecasts On Legence Following Q2 Results

Legence Corp (NASDAQ: LGN) reported mixed second-quarter results, missing earnings estimates but exceeding sales expectations. Following the announcement, BTIG analyst Gregory Lewis reiterated a Buy rating but lowered the price target from $120 to $100, while BMO Capital analyst Devin Dodge maintained an Outperform …

Generation Income Properties (GIPR) sees 9.99% stake reported by Armistice Capital

Armistice Capital, LLC and Steven Boyd have reported a 9.99% beneficial ownership stake in Generation Income Properties (GIPR), totaling 109,911 shares. This disclosure was made via a Schedule 13G SEC filing, indicating a passive investment. The shares are held by Armistice Capital Master Fund …

Is BeOne Medicines AG (ONC) Deal With Revolution Medicines (RVMD) a Win-Win for Both Companies?

Two oncology powerhouses, BeOne Medicines AG (NASDAQ:ONC) and Revolution Medicines, Inc. (NASDAQ:RVMD), announced a major multi-part clinical collaboration and regional licensing deal. Under the August 10 agreement, the companies will combine select clinical-stage assets from BeOne with Revolution's four clinical-stage RAS(ON) inhibitors to evaluate …

Forgent Power Solutions (FPS) gains 7.5% beneficial holder in Coatue and Laffont

Legence (LGN) Stock Jumps As Backlog Strength Recasts Loss Concerns

Generation Income (GIPR) details Q2 10-Q delay, says report is now filed

Fund 1 Investments (GCO) discloses 5.49% Genesco ownership via 609,963 shares

Fund 1 Investments, LLC has reported a 5.49% beneficial ownership in Genesco Inc., holding 609,963 shares of common stock. These shares are held through private investment vehicles advised by Pleasant Lake Partners LLC, with Fund 1 Investments serving as the managing member. The firm …

Generation Income (GIPR) raises cash but flags survival risk

Is UroGen Pharma (URGN) Overvalued As Sales Growth And Patent Clarity Lift Confidence?

Is Biohaven (BHVN)’s Latest Regeneron Pharmaceuticals (REGN) Deal a Major Catalyst for its Pipeline?

Two prominent biopharmaceutical names, Biohaven Ltd. (NYSE:BHVN) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), are deepening their relationship across oncology. On July 20, Biohaven announced a clinical supply agreement with Regeneron to evaluate the combination of BHV-1530 and Regeneron's cemiplimab (Libtayo) in patients with solid tumors. …

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 4,000 Shares of Stock

SOPHiA GENETICS (NASDAQ:SOPH) insider Zhenyu Xu sold 4,000 shares of the company's stock on August 13th for $30,080, reducing his position by 0.68%. This sale was part of a pre-arranged Rule 10b5-1 trading plan, and Xu has made several other sales since early July. …

Vistagen Therapeutics (VTGN): OrbiMed reports 0.0% beneficial ownership in latest 13G/A

BioNexus Gene Lab Corp (BGLC) grants CEO 338,709 fully vested shares

BioNexus Gene Lab Corp (BGLC) announced that its CEO and director, Tan Lee Su-Leng, received a fully vested stock award of 338,709 common shares. These shares, granted under the company's 2025 Equity Incentive Plan for completed services, were valued at $1.55 per share based …

BioNexus Gene Lab Corp (BGLC) director receives 32,258-share equity award

BioNexus Gene Lab Corp director Bin Abdul Hamid Muhammad Azrul received a fully vested equity award of 32,258 common shares on August 13, 2026. The award, valued at $1.55 per share, was granted under the company’s 2025 Equity Incentive Plan for completed services, with …

BioNexus Gene Lab Corp (BGLC) director granted 16,129-share fully vested stock award

BioNexus Gene Lab Corp (BGLC) director Low Jook Yuen received a fully vested stock award of 16,129 shares of common stock on August 13, 2026, for services rendered. This equity compensation, granted under the company's 2025 Equity Incentive Plan, had no cash consideration and …

Perceptive Advisors (NASDAQ: ENGN) discloses 9.99% beneficial stake with warrant cap

Perceptive Advisors, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a 9.99% beneficial ownership stake in enGene Holdings Inc. (NASDAQ: ENGN). This stake includes both common shares and pre-funded warrants, with the exercise of warrants capped at 9.99% ownership due to …

The Bull Case For Dollar General (DG) Could Change Following Management’s Cautious Consumer and Sales Outlook – Learn Why

Dollar General's management has expressed caution regarding consumer spending due to inflation, high gas prices, and reduced SNAP benefits, maintaining an unchanged annual same-store sales growth outlook of 2.2% to 2.7%. This cautious stance from management contrasts with some analysts' more optimistic views based …

RA Capital reports 9.99% TSHA stake in Taysha Gene Therapies (TSHA)

RA Capital Management and affiliated funds have filed an amended Schedule 13G, disclosing a beneficial ownership of 9.99% in Taysha Gene Therapies (TSHA) common stock as of June 30, 2026. This ownership includes common shares and a portion of pre-funded warrants, capped by a …

Adagene (ADAG): WuXi PharmaTech and WuXi AppTec disclose 3.5% beneficial stake

WuXi PharmaTech Healthcare Fund I L.P. and its indirect parent WuXi AppTec Co., Ltd. have filed an amended Schedule 13G, disclosing a 3.5% beneficial ownership in Adagene Inc. (ADAG). As of June 30, 2026, they collectively own 2,891,594 ordinary shares, held in the form …

MRV (MRVE3): prejuízo de R$ 627 milhões no consolidado e alta de 14% na ação

Diana Shipping withdraws Genco bid as takeover terms hit a roadblock

Bjoern Wylezich Diana Shipping (DSX [https://seekingalpha.com/symbol/DSX]) announced on Friday that it has withdrawn its offer to acquire the remaining shares of Genco Shipping & Trading (GNK [https://seekingalpha.com/symbol/GNK]) after the companies failed to agree on deal terms. The company's withdrawn offer [https://seekingalpha.com/pr/20620174-diana-shipping-inc-withdraws-offer-to-acquire-genco-shipping-and-trading-following-genco] included $24.80 in …